Reardon, David A.
Wen, Patrick Y.
Article History
First Online: 6 January 2015
Competing interests
: D.A.R. has served as a consultant and received honoraria from Amgen, Apogenix, EMD Serono, Genentech/Roche, Merck/Schering-Plough, Momenta Pharmaceuticals, Novartis and Stemline Therapeutics. P.Y.W. has served as a consultant and received honoraria from Abbvie, Celldex, Foundation Medicine, Genentech/Roche, Novartis, Momenta Pharmaceuticals and Sigma Tau.